UCLA Radiation Oncology Workshop : Integration of State-of-the-Art Innovations into Clinical Radiation Oncology Practice is organized by David Geffen School of Medicine at UCLA and would be held during Jun 9 - 10, 2017 at Neuroscience Research Building (NRB) Auditorium - UCLA Campus, Los Angeles, California, United States of America. This cme conference has been approved with a maximum of 11.75 AMA PRA Category 1 Credits.
Target Audience
Radiation oncologists, medical physicists, medical oncologists, surgical oncologists, and biologists interested in implementing recent advances related to radiation treatment delivery, integrations of biological and technological advances in cancer care into daily radiation oncology practice, and having exposure to novel approaches in cancer detection, radiation treatment planning, and treatment delivery. Objectives
At the conclusion of the course, participants should be better able to:
• List the indications for thoracic SBRT and techniques that offer the best outcome using this technique in early stage lung cancer and thoracic oligometastases
• Discuss the limitation of current motion management strategies and the advantages brought by model based breathing motion management
• List the indications of SBRT and high-dose-rate brachytherapy for prostate cancer and how best to integrate radiation therapy in the management of high-risk prostate cancer
• Deliver the various newer breast irradiation techniques such as accelerated partial breast irradiation, prone breast irradiation, and deep inhale breath-hold technique, and understand their roles in the multi-disciplinary management for breast cancer
• Describe the roles of various radiation modalities for primary and metastatic brain tumors and understand how best to incorporate these techniques for treatment of malignant brain tumors
• Discuss practical considerations in implementing a novel planning and treatment delivery approach using ultra-compact radiation dose distribution
• Recognize the current and future role of MRI in radiation therapy and how to best integrate this newer imaging modality into the current radiation oncology work-flow